Nano-X Imaging (NNOX) Net Cash Flow (2021 - 2026)
Nano-X Imaging (NNOX) posted quarterly Net Cash Flow of -$5.3 million for Q1 2026, down 596.89% year-on-year from $1.1 million in Q1 2025, and down 232.03% on a QoQ basis from $4.0 million in Q4 2025.
Nano-X Imaging (NNOX) Net Cash Flow (2021 - 2026) Analysis & Trends
Nano-X Imaging (NNOX) has reported Net Cash Flow for 6 consecutive years, with -$5.3 million the latest figure, recorded in Q1 2026.
- Quarterly Net Cash Flow fell 596.89% year-over-year to -$5.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.6 million (up 178.6% YoY) and the FY2025 annual result came in at $9.9 million, up 158.02% from the prior year.
- Net Cash Flow eased to -$5.3 million in Q1 2026 per NNOX's latest filing, from $4.0 million in the prior quarter.
- Over the last five years, Net Cash Flow for NNOX reached as high as $24.6 million in Q3 2023 and fell as low as -$11.7 million in Q1 2022.
- A 5-year average of -$1.3 million and a median of -$1.7 million in 2022 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2023 — Net Cash Flow jumped 315.14% — and 2024, when it slumped 1202.15%.
- Year by year, Net Cash Flow stood at -$1.7 million in 2022, then sank by 505.04% to -$10.2 million in 2023, then surged by 110.42% to $1.1 million in 2024, then jumped by 275.28% to $4.0 million in 2025, then sank by 232.03% to -$5.3 million in 2026.
- According to Business Quant data, Net Cash Flow over the past three periods registered -$5.3 million, $4.0 million, and -$4.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -1.70 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.11 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 768.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -503.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -500.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 202.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.19 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Nano-X Imaging | 67.53 Mn | 23.68 Mn | -2.59 Mn | -5.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.27 Mn |
| Mar 31, 2026 | -5.27 Mn |
| Dec 31, 2025 | 3.99 Mn |
| Dec 31, 2025 | 3.99 Mn |
| Sep 30, 2025 | -4.74 Mn |
| Sep 30, 2025 | -4.74 Mn |
| Jun 30, 2025 | 9.64 Mn |
| Jun 30, 2025 | 9.64 Mn |
| Mar 31, 2025 | 1.06 Mn |
| Mar 31, 2025 | 1.06 Mn |
| Dec 31, 2024 | 1.06 Mn |
| Dec 31, 2024 | 1.06 Mn |
| Sep 30, 2024 | -771,000.00 |
| Sep 30, 2024 | -771,000.00 |
| Jun 30, 2024 | -5.95 Mn |
| Jun 30, 2024 | -5.95 Mn |
| Mar 31, 2024 | -11.49 Mn |
| Mar 31, 2024 | -11.49 Mn |
| Dec 31, 2023 | -10.21 Mn |
| Dec 31, 2023 | -10.21 Mn |